Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Share-based Compensation (2018 - 2021)

Historic Share-based Compensation for Regenerative Medical Technology (RMTG) over the last 4 years, with Q4 2021 value amounting to $10000.0.

  • Regenerative Medical Technology's Share-based Compensation changed N/A to $10000.0 in Q4 2021 from the same period last year, while for Sep 2025 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $455.0 for FY2023, which is 9545.0% down from last year.
  • According to the latest figures from Q4 2021, Regenerative Medical Technology's Share-based Compensation is $10000.0.
  • In the past 5 years, Regenerative Medical Technology's Share-based Compensation ranged from a high of $166595.0 in Q2 2020 and a low of -$280.0 during Q2 2018
  • Over the past 4 years, Regenerative Medical Technology's median Share-based Compensation value was $307.0 (recorded in 2018), while the average stood at $18092.5.
  • Per our database at Business Quant, Regenerative Medical Technology's Share-based Compensation skyrocketed by 8319750.0% in 2020 and then tumbled by 9399.74% in 2021.
  • Regenerative Medical Technology's Share-based Compensation (Quarter) stood at $1819.0 in 2018, then plummeted by 89.0% to $200.0 in 2019, then skyrocketed by 83197.5% to $166595.0 in 2020, then crashed by 94.0% to $10000.0 in 2021.
  • Its last three reported values are $10000.0 in Q4 2021, $10000.0 for Q2 2021, and $10000.0 during Q1 2021.